InfuSystem Holdings, Inc (INFU) company profile
Close on Nov 17, 2026Market cap $294.58MP/E 36.1Yield –
About InfuSystem
Surgical & Medical Instruments & Apparatus, SIC 3841
InfuSystem Holdings, Inc. operates as a healthcare service provider facilitating outpatient care for durable medical equipment manufacturers and healthcare providers. The company provides ambulatory infusion pumps, negative pressure wound therapy devices, related disposable supplies, and biomedical services, including inspection, repair, and certification. Business activities are organized into two operational segments: Patient Services and Device Solutions. Patient Services focuses on clinic-to-home healthcare delivery, continuous chemotherapy infusion, pain management, and wound care, accompanied by third-party billing and clinical support. Device Solutions provides equipment sales, rentals, consumable distribution, and direct biomedical maintenance services to clinical practices. InfuSystem serves hospitals, oncology practices, ambulatory surgery centers, infusion clinics, home care providers, skilled nursing facilities, and acute care facilities.
The company is headquartered in Rochester Hills, Michigan. InfuSystem conducts its business operations across seven locations situated in the United States and Canada, which also house service and repair centers. In addition, the company maintains business relationships with oncologists in approximately 2,100 outpatient oncology clinics and has contracts with nearly 840 third-party payer networks.
Summary of the business section of InfuSystem's latest annual report, written by StockData.
Company profile
Company
- Legal name
- InfuSystem Holdings, Inc
- Founded
- 2005
- Headquarters
- Rochester Hills, MI
- Address
- 3851 West Hamlin Road 48309
- Phone
- (248) 291-1210
- Website
- infusystem.com
- Employees
- 473, Dec 31, 2025
- Industry
- Surgical & Medical Instruments & Apparatus
- Incorporated in
- Delaware
- Fiscal year ends
- December 31
- Auditor
- Deloitte & Touche LLP, Detroit, Michigan
Stock & identifiers
- Ticker
- INFU
- Exchange
- NYSE
- IPO date
- Apr 12, 2006
- Shares outstanding
- 20M, Jul 31, 2026
- Public float
- $122.27M, Jun 30, 2025
- Filer category
- Accelerated filer<br>Smaller reporting company
- SEC CIK
- 1337013
- CUSIP
- 45685K102
- ISIN
- US45685K1025
- FIGI
- BBG000P0ZZR6
- Share class FIGI
- BBG001SQTYK1
- LEI
- 549300F58N8PHJ4QUI59
- EIN
- 20-3341405
Executives and directors
Officers and directors who filed ownership reports (Forms 3, 4, 5) in the last two years
| Name | Position | Shares owned |
|---|---|---|
| Carrie Lachance | President and CEO, Director | 266,391 |
| Richard Dilorio | Chief Executive Officer, Director | 447,925 |
| Jerod Funke | EVP-Chief HR Officer | 34,710 |
| Addam Chupa | Executive VP and CIO | 61,160 |
| Barry G. Steele | Executive VP and CFO | 121,567 |
| Scott Shuda | Director | 372,383 |
| John J. Sviokla | Director | 10,000 |
| Kenneth D. Eichenbaum | Director | 6,000 |
| Ronald T. Hundzinski | Director | 5,000 |
| Beverly A. Huss | Director | 4,300 |
| Paul Andrew Gendron | Director | 70,000 |
CEO pay and shareholder return
Pay versus performance table from the proxy statement
| Fiscal year | CEO total pay | CEO pay actually paid | Other executives (avg) | Value of $100 invested | Peer group |
|---|---|---|---|---|---|
| FY2025 | $2.91M | $4.47M | $1.27M | $103 | – |
| FY2024 | $2.52M | $1.81M | $1.27M | $50 | – |
| FY2023 | $2.29M | $2.41M | $1.21M | $62 | – |
| FY2022 | $1.55M | $109.09K | $821.18K | $51 | – |
“Actually paid” adjusts reported pay for changes in the value of equity awards. Shareholder return assumes $100 invested at the start of the measurement period, as disclosed by the company.
Executive compensation, fiscal 2025
Summary compensation table from the latest proxy statement
| Executive | Salary | Bonus | Stock awards | Option awards | Other | Total | vs. prior year |
|---|---|---|---|---|---|---|---|
| Carrie Lachance Chief Executive Officer | $478.89K | $500.00K | $1.35M | $566.48K | $19.92K | $2.91M | +126% |
| Richard DiIorio Former Chief Executive Officer | $278.65K | $264.60K | – | – | $732.18K | $1.28M | -49% |
| Barry Steele Executive Vice President and Chief Financial Officer | $432.60K | $309.56K | $540.75K | $149.92K | $20.04K | $1.45M | +16% |
| Jerod Funke Executive Vice President, Chief Human Resources Officer | $373.10K | $223.86K | $373.10K | $103.44K | $20.94K | $1.09M | +17% |
Stock and option awards are grant-date fair values, not realized pay. “Other” includes pension value changes and all other compensation. Source proxy statement.
IPO
From the final prospectus (Form 424B4) and the first day of trading
SPAC offering
- Type
- SPAC (blank check) IPO of units
- Final prospectus filed
- Apr 12, 2006
- Securities offered
- 16,666,667
- First trading day
- Dec 27, 2007
- First-day close
- $3.75
- Lock-up ends (est.)
- Jun 24, 2008
Lock-up end is estimated as 180 days after the first trading day; the prospectus sets the actual terms.
Employees
Headcount reported in annual reports
“As of December 31, 2025, we had 473 employees, including 461 full-time employees and 12 part-time or contract employees.”
Corporate history
Events identified from SEC filings
See a number that looks wrong?